Skip to main content

Johnson & Johnson to Participate in the Goldman Sachs 44th Annual Global Healthcare Conference

Johnson & Johnson (NYSE: JNJ) will participate in the Goldman Sachs 44th Annual Global Healthcare Conference on Tuesday, June 13th, at the Waldorf Astoria Monarch Beach Resort & Club in Dana Point, CA. Biljana Naumovic, Worldwide Vice President, Oncology, and Peter Lebowitz, Global Therapeutic Head, Oncology, will represent the Company in a session scheduled at 4:20 p.m. (Eastern Time).

This webcast will be available to investors and other interested parties by accessing the Johnson & Johnson website at www.investor.jnj.com.

A webcast replay will be available approximately 48-hrs after the live webcast.

Recent Quotes

View More
Symbol Price Change (%)
AMZN  228.32
+7.05 (3.19%)
AAPL  273.07
+1.24 (0.45%)
AMD  204.01
+5.90 (2.98%)
BAC  54.59
+0.04 (0.06%)
GOOG  304.04
+5.98 (2.00%)
META  668.02
+18.52 (2.85%)
MSFT  488.75
+12.62 (2.65%)
NVDA  175.64
+4.70 (2.75%)
ORCL  182.38
+3.92 (2.20%)
TSLA  489.57
+22.31 (4.77%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.